Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CN105859703A patent route for Brexpiprazole using 7-hydroxycoumarin. Reduces impurities, lowers cost, ensures supply chain stability for pharma manufacturing.
Novel chemical route from 1,3-dichloropropene offers cost reduction and scalable high-purity pentanediamine production for industrial supply chains.
Patent CN104693020A details a high-purity synthesis route for Cinacalcet intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115850188A reveals a high-yield synthesis for benzimidazole intermediates used in electronic polyimides, offering superior purity and scalable manufacturing capabilities.
Patent CN1511826A introduces a robust ketone-based route for beta-amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharma.
Patent CN115181054B reveals metal-free cross-dehydrogenation coupling for 3-benzylindole compounds ensuring cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113135831A reveals a safer 2-step synthesis for alminoprofen intermediates, eliminating Raney nickel risks and significantly reducing industrial waste generation.
Patent CN1483017A details a high-purity synthesis of 1,5-naphthalenediamine from o-nitrotoluene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101817779A reveals a novel nickel-catalyzed route for N-benzyl-3-piperidinol, offering safer manufacturing and significant cost reduction for Benidipine intermediates.
Patent CN112898198B reveals a novel Suzuki coupling route for synthesizing high-purity nitrogen-containing aromatic heterocyclic diamines, offering significant cost reduction and scalability for polyimide manufacturing.
Patent CN115605457B reveals a safer methylation process using dimethyl carbonate. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN108676048B reveals a novel adenosine-based route for cordycepin. Achieve high purity and cost reduction in nucleoside manufacturing with scalable catalytic transfer hydrogenation.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Novel DBH inhibitors synthesis via hydrazone cyclization. Cost-effective route for antihypertensive intermediates with high purity specifications.
Patent CN116120145A reveals a cost-effective route for 2-chloro-3-fluorotoluene via by-product valorization, offering high-purity agrochemical intermediates.
Patent CN105873897B reveals mild amine synthesis. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN112110804B reveals a novel synthesis route for 3,5-dihalo trifluoroacetophenone derivatives, offering high purity and scalable industrial production capabilities.
Patent CN103347847A reveals a continuous method for high-purity diamine production, offering significant cost reduction in fine chemical manufacturing and enhanced supply reliability.
Patent CN110483265A reveals Pd-catalyzed oxidative dehydrogenation for high-purity dienal manufacturing. Offers cost reduction and supply chain reliability for global pharmaceutical intermediates.
Patent CN102603615B reveals a low-cost route for Halofuginone intermediates using methoxyacetone, replacing expensive rhodium catalysts with palladium-carbon for scalable production.